CORV 0.37$ CHINESE FLU LINKED PLAYER WITH ALREADY APPROVED DRUGS, INCLUDING AN ANTIBIOTIC FOR COMMUNITY ACQUIRED PNEUMONIA. A LOT OF MARKETED DRUGS IN THEIR COMMERCIAL PORTFOLIO,MANAGEMENT CLOSER TO ASSET SALE, M&A, PARTNERSHIP. LOW OS LOW FLOAT 3X ALMOST GUARANTEED, CO. WILL BE MEETING ASAP WITH FDA TO DISCUSS THE SAFETY TRIAL FOR BRINAVESS EFFECTIVE DRUG IN THE CARDIOVASCULAR FIELD WITH A POTENTIAL 500/1000 MLN DOLLARS, PATENT EXTENSION TO 2031. ULTRABULLISH ABOUT CORV, WILL BE 1$ STOCK AGAIN, CHINESE FDA OR SFDA SHOULD APPROVE BRINAVESS IN CHINA, A BILLION DOLLAR MARKET, POTENTIALLY SENDING STOCK TO THE MOON!!!